P53 deletion is not a frequent event in multiple myeloma
- 1 September 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 106 (3) , 717-719
- https://doi.org/10.1046/j.1365-2141.1999.01615.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 9 references indexed in Scilit:
- Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose ChemotherapyBlood, 1998
- The Ig Heavy Chain Gene Is Frequently Involved in Chromosomal Translocations in Multiple Myeloma and Plasma Cell Leukemia as Detected by In Situ HybridizationBlood, 1997
- Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia.British Journal of Haematology, 1997
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemiaBlood, 1996
- p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasBlood, 1995
- p53 gene mutations in multiple myeloma are associated with advanced forms of malignancyBlood, 1993
- Rare occurrence of P53 gene mutations in multiple myelomaBritish Journal of Haematology, 1992